Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Johnson & Johnson. FDA records under its name, each linked to the record. See the Johnson & Johnson group view.
As of Nov 21, 2026, FDA's public records list Actelion Pharmaceuticals U.S. with 1 drug recall. The most recent is a drug recall dated Jan 16, 2013: Ventavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per….
| Date | Record | Source |
|---|---|---|
| Jan 16, 2013 | Ventavis (iloprost) Inhalation Solution, 10 mcg/1 mL, Sterile, 30 Single Use Ampules per carton, Manufactured for Actelion Pharmaceuticals…Class III · Subpotent Drug: OOS (out of specification) assay result at the 12 month stability time point. | Drug recall |
What this company reported paying US doctors and teaching hospitals each year, $1.1M of it for research; see every company
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.